Colesevelam now included in ACE/AACE guide as combination therapy for glycemic control


Bile sequestrant colesevelam now included in endocrinologist groups' diabetes guide.

The American College of Endocrinologists (ACE) and the American Association of Endocrinologists (AACE) have included colesevelam (Welchol, Daiichi Sankyo), a bile acid sequestrant, as an option for treating patients with Type 2 diabetes in their Road Maps to Achieve Glycemic Control in

Related Videos
fake news misinformation | Image Credit: Bits and Splits -
Dr. Charles Lee
© 2024 MJH Life Sciences

All rights reserved.